Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001567264-24-000052
Filing Date
2024-11-13
Accepted
2024-11-13 16:01:04
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q intensity-20240930.htm   iXBRL 10-Q 856619
2 EX-31.1 a10q20240930exhibit311.htm EX-31.1 11206
3 EX-31.2 a10q20240930exhibit312.htm EX-31.2 11186
4 EX-32.1 a10q20240930exhibit321.htm EX-32.1 5514
5 EX-32.2 a10q20240930exhibit322.htm EX-32.2 5496
  Complete submission text file 0001567264-24-000052.txt   4682324

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20240930.xsd EX-101.SCH 35492
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT intensity-20240930_cal.xml EX-101.CAL 45810
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT intensity-20240930_def.xml EX-101.DEF 134193
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20240930_lab.xml EX-101.LAB 504407
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20240930_pre.xml EX-101.PRE 341082
68 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20240930_htm.xml XML 443976
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41109 | Film No.: 241453838
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)